Literature DB >> 8549286

Veterinary use of new quinolones in Japan.

S Nakamura1.   

Abstract

Five new quinolones are used as veterinary medicines in Japan. Benofloxacin and ofloxacin are orally given in feed or in drinking water for respiratory diseases due to Mycoplasma spp. and Escherichia coli in poultry. Enrofloxacin is subcutaneously, intramuscularly or orally administered to cattle and swine for pneumonia due to Pasteurella spp., Mycoplasma spp. and Actinobacillus pleuropneumoniae and diarrhoea due to E. coli, and is used orally for respiratory diseases in poultry. Danofloxacin is similar to enrofloxacin except that the former is not approved for diarrhoea in cattle and swine. Orbifloxacin is given intramuscularly for pneumonia and diarrhoea in cattle and swine but not for poultry diseases. They are effective and safe in animals, and disappear from edible tissues after appropriate drug withdrawal times. The quinolones are indicated only when first-choice drugs are ineffective, only under the direction of veterinarians and only for periods of less than 5 days. Under these conditions, it appears unlikely that quinolone use in veterinary practice will be detrimental to human chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549286     DOI: 10.2165/00003495-199500492-00025

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  21 in total

Review 1.  Plasmid-mediated 4-quinolone resistance: a real or apparent absence?

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Effect of enrofloxacin therapy on shipping fever pneumonia in feedlot cattle.

Authors:  P Lekeux; T Art
Journal:  Vet Rec       Date:  1988-08-20       Impact factor: 2.695

3.  [Susceptibilities of Escherichia coli, Salmonella and Staphylococcus aureus isolated from animals to ofloxacin and commonly used antimicrobial agents].

Authors:  I Takahashi; T Yoshida; Y Higashide; T Sakano
Journal:  Jpn J Antibiot       Date:  1990-01

4.  Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-q uinoline- carboxylic acid (BAY Vp 2674) in chickens.

Authors:  G M Conzelman; J G Babish; J N Davidson; R A McMillan; D D Copeland
Journal:  Proc West Pharmacol Soc       Date:  1987

5.  Confirmation of danofloxacin residues in chicken and cattle liver by microbore high-performance liquid chromatography electrospray ionization tandem mass spectrometry.

Authors:  R P Schneider; J F Ericson; M J Lynch; H G Fouda
Journal:  Biol Mass Spectrom       Date:  1993-10

6.  A comparison of the efficacy of danofloxacin and tylosin in the control of Mycoplasma gallisepticum infection in broiler chicks.

Authors:  F T Jordan; B K Horrocks; S K Jones; A C Cooper; C J Giles
Journal:  J Vet Pharmacol Ther       Date:  1993-03       Impact factor: 1.786

7.  The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves.

Authors:  W T Grimshaw; C J Giles; A C Cooper; D J Shanks
Journal:  Dtsch Tierarztl Wochenschr       Date:  1990-12

Review 8.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  A comparison of danofloxacin and tylosin in the control of induced Mycoplasma gallisepticum infection in broiler chicks.

Authors:  A C Tanner; A P Avakian; H J Barnes; D H Ley; T T Migaki; R A Magonigle
Journal:  Avian Dis       Date:  1993 Apr-Jun       Impact factor: 1.577

10.  Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia.

Authors:  M D Apley; D W Upson
Journal:  Am J Vet Res       Date:  1993-06       Impact factor: 1.156

View more
  5 in total

1.  Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares.

Authors:  G R Haines; M P Brown; R R Gronwall; K A Merritt; L K Baltzley
Journal:  Can J Vet Res       Date:  2001-07       Impact factor: 1.310

2.  Disposition kinetics of orbifloxacin in tissues of crucian carp (Carassius auratus) following a single intramuscular administration.

Authors:  Y R Yang; F Yang; N Sun; G Y Wang
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

3.  Development and validation of a microbiological agar assay for determination of orbifloxacin in pharmaceutical preparations.

Authors:  Edith C L Cazedey; Hérida R N Salgado
Journal:  Pharmaceutics       Date:  2011-08-29       Impact factor: 6.321

4.  Pharmacokinetics of intravenous and intramuscular danofloxacin in red-eared slider turtles (Trachemys scripta elegans).

Authors:  Orhan Corum; Duygu Durna Corum; Feray Altan; Ayse Er; Gul Cetin; Kamil Uney
Journal:  J Vet Med Sci       Date:  2019-03-11       Impact factor: 1.267

5.  Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.

Authors:  Kazuki Harada; Masaru Usui; Tetsuo Asai
Journal:  J Vet Med Sci       Date:  2014-07-10       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.